X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (7) 7
oncology (7) 7
aged (5) 5
adult (4) 4
female (4) 4
male (4) 4
middle aged (4) 4
therapy (4) 4
treatment outcome (4) 4
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
chemotherapy (3) 3
cohort studies (3) 3
double-blind (3) 3
gastric cancer (3) 3
lung cancer (3) 3
oxaliplatin (3) 3
1st-line therapy (2) 2
1st-line treatment (2) 2
acquired-resistance (2) 2
biomarkers, tumor - metabolism (2) 2
cancer (2) 2
capecitabine (2) 2
cisplatin (2) 2
clinical trials (2) 2
disease progression (2) 2
disease-free survival (2) 2
fluorouracil (2) 2
gene amplification (2) 2
health aspects (2) 2
hospital mortality (2) 2
internal medicine (2) 2
kinases (2) 2
medicine & public health (2) 2
monoclonal antibody (2) 2
mutation (2) 2
non-small cell lung carcinoma (2) 2
open-label (2) 2
patients (2) 2
phase-iii (2) 2
prognosis (2) 2
protein-tyrosine kinase (2) 2
risk (2) 2
stomach (2) 2
stomach neoplasms - drug therapy (2) 2
stomach neoplasms - pathology (2) 2
survival (2) 2
targeted therapy (2) 2
trastuzumab (2) 2
trial (2) 2
tumors (2) 2
young adult (2) 2
1st-line chemotherapy (1) 1
abdominal surgery (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adolescent (1) 1
advanced disease (1) 1
aged patients (1) 1
analysis (1) 1
anaplastic lymphoma kinase - genetics (1) 1
anestesi och intensivvård (1) 1
anesthesiology (1) 1
anesthesiology and intensive care (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
animals (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
articles (1) 1
austria (1) 1
bevacizumab (1) 1
binding sites (1) 1
biomarkers (1) 1
brain radiation-therapy (1) 1
breast-cancer (1) 1
c-met protein (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
cancer research (1) 1
cancer therapies (1) 1
cancer-surgery (1) 1
carboplatin-paclitaxel (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
care and treatment (1) 1
central nervous system (1) 1
clinical next-generation sequencing (1) 1
clinical-trials (1) 1
cohort (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 6/2018, Volume 78, Issue 9, pp. 893 - 911
Lung cancer is the second most common malignant tumor and the leading cause of cancer death. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | TYROSINE KINASE INHIBITORS | PHASE-III TRIAL | RECEPTOR GENE-MUTATIONS | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | BRAIN RADIATION-THERAPY | ACQUIRED-RESISTANCE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | OPEN-LABEL | TOXICOLOGY | GEFITINIB RESISTANCE | Piperazines - administration & dosage | Lung Neoplasms - drug therapy | ErbB Receptors - metabolism | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | ErbB Receptors - genetics | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Piperazines - adverse effects | Disease Progression | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Agents - adverse effects | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Therapy | Epidermal growth factor receptors | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Radiation therapy | Kinases | Patients | Survival | ErbB-2 protein | Metastases | c-Met protein | Epidermal growth factor | Inhibitors | Immunotherapy | Mutation | Growth factors | Protein-tyrosine kinase | Cancer | Tumors
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 03/2019, Volume 15, Issue 7, pp. 705 - 716
Personalized patient-precise medicine is being gradually incorporated into clinical practice for the treatment of non-small-cell lung cancer (NSCLC). The EGFR... 
targeted therapy | 1ST-LINE TREATMENT | PLUS CHEMOTHERAPY | NSCLC | EGFR inhibitor | epidermal growth factor receptor | SQUIRE trial | necitumumab | PHASE-II | OPEN-LABEL | INSPIRE trial | EGFR-EXPRESSION | EGFR | SQUAMOUS CARCINOMA | GROWTH-FACTOR RECEPTOR | THERAPY | CISPLATIN | ONCOLOGY | IMC-11F8 | QUALITY-OF-LIFE | monoclonal antibody | non-small-cell lung cancer | squamous cell carcinoma
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9847, pp. 1059 - 1065
Journal Article
Future oncology (London, England), 03/2019, Volume 15, Issue 7, p. 705
Personalized patient-precise medicine is being gradually incorporated into clinical practice for the treatment of non-small-cell lung cancer (NSCLC). The EGFR... 
Journal Article
Gastric Cancer, ISSN 1436-3291, 5/2017, Volume 20, Issue 3, pp. 465 - 474
Journal Article
European Respiratory Journal, ISSN 0903-1936, 05/2018, Volume 51, Issue 5, pp. 1702431 - 1702431
Thromboembolic disease is fairly common in patients with lung cancer [1–3]. This incidence seems to be higher in patients with lung adenocarcinomas [4], with... 
CRIZOTINIB | RISK | MODEL | VENOUS THROMBOEMBOLISM | RESPIRATORY SYSTEM | Disease | Lung cancer | Lung diseases | Non-small cell lung carcinoma | Thromboembolism | Health risk assessment | Lymphoma | Protein-tyrosine kinase | Tumors
Journal Article